Last updated: 2026-10-14 00:33:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Dyadic International, Inc. (DYAI) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.41, with a market capitalization of $17.79M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.34 to $1.60. This page covers its latest market performance, valuation, price trends and company information.
$17.79M | |
$0.43 | |
$10.98 | |
$0.34 | |
$0.42 | |
46.74K | |
188.85K | |
-- | |
$1.60 | |
$0.34 | |
-- | |
-- |
Dyadic International, Inc. (DYAI) last closed at $0.42 as of 2026-10-13 20:02:00, unchanged from the previous close of $0.42.
During the latest regular trading session, DYAI traded between $0.34 and $10.98, with a volume of 46.74K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Dyadic International, Inc. (DYAI) moved from $0.46 to $0.41, representing a decline of 9.17% ($0.04).
The stock traded between $0.40 and $0.49 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 86.73 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 5.9%
DYAI is currently trading at $0.41, placing it 5.9% of the way from its 52-week low of $0.34 to its 52-week high of $1.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 5 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Dyadic International, Inc. (DYAI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.